The BRC is part of a new collaboration to accelerate cancer research, translating scientific discoveries into tangible benefits for patients.
The NIHR Oncology Translational Research Collaboration (TRC) brings together leading cancer researchers from across the NIHR’s BRCs to drive forward research in key areas including early diagnosis, surgery, immunotherapy and radiotherapy.
The collaboration will be chaired by the BRC at The Royal Marsden and The Institute of Cancer Research, London.
The lead at the UCLH BRC will be Professor Daniel Hochhauser.
Louise Knowles, Head of Research Faculty, Infrastructure and Growth at the Department of Health and Social Care, said:
“It is fantastic to see our nation’s leading oncology expertise coming together to maximise the impact of the ground breaking research taking place in the NIHR’s Biomedical Research Centres. Our experience from Covid-19 has clearly demonstrated that collaborative working can drive forward life saving research. By pooling collective expertise, the Oncology TRC has the potential to accelerate innovations and provide real benefit for people with cancer.”
The Oncology TRC will share expertise and best practice, map the landscape to identify gaps in research and areas of unmet need, and identify opportunities to work with external partners including industry and charities.
Visit the Oncology TRC website to find out more.
Image: peterschreiber.media / Adobe Stock
